Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF

R&D Systems | Catalog # 11201-GH

CHO-expressed (aa 28-653 H33Q)
R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems CHO-derived Recombinant Human alpha-L-Iduronidase/IDUA His Protein (11201-GH)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

P35475.2

Applications

Enzyme Activity
View all alpha-L-Iduronidase/IDUA Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human alpha-L-Iduronidase/IDUA protein
Ala28-Pro653 (His33Gln), with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ala28

Predicted Molecular Mass

71 kDa

SDS-PAGE

80-91 kDa, under reducing conditions.

Activity

Measured by its ability to cleave a fluorogenic substrate, 4-Methylumbelliferyl  alpha -L-iduronide.
The specific activity is >6000 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF

Recombinant Human alpha-L-Iduronidase/IDUA His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human alpha-L-Iduronidase/IDUA His-tag Protein (Catalog # 11201-GH) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 80-91 kDa.

Formulation, Preparation, and Storage

11201-GH
Formulation Supplied as a 0.2 μm filtered solution in Sodium Acetate, NaCl and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: alpha-L-Iduronidase/IDUA

alpha -L-Iduronidase is a member of the glycoside hydrolase family encoded by the IDUA gene (1). It is an important enzyme required for the lysosomal degradation of glycosaminoglycans (GAGS) and hydrolyzes the non-reducing terminal a-L-iduronic acid residues in GAGS including dermatan sulfate and heparan sulfate.  Human IDUA is a 653 aa protein composed of a signal peptide removed in the lysosome for mature form and three domains: a triosephosphate isomerase barrel fold containing the catalytic site, a B-sandwich domain, and an Ig(Ig)-like domain. The protein has six reported N-glycosylation sites and the glycosylation status of the enzyme correlates with its catalytic activity (1). More than a hundred disease-associated variants in the IDUA gene have been identified (1-2). Mutations in IDUA that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I) (3). MPS I can be classified into three clinical subtypes; Hurler syndrome, Hurler-Scheie syndrome, and Scheie syndrome with decreasing severity, respectively. MPS I causes progressive cellular, tissue and organ damage, and several clinical studies using enzyme replacement therapy show positive results (4,5). More recently, the IDUA gene has been linked to osteoporosis (6,7). H33Q, present in the recombinant product, represents a benign and common polymorphism (8).

References

  1. Maita, N. et al. (2013) Proc. Natl. Acad. Sci. 110:14628.
  2. Borges, P. et al. (2021) Front. Mol. Biosci. 8:752797.
  3. Scott, H.S. et al. (1995) Hum. Mutat. 6:288.
  4. Wraith, J.E. (2005) Expert Opin. Pharmacother. 6:489.
  5. Jameson, E. (2016) Cochrane Database Syst. Rev. 4:CD009354.
  6. Kodric, K. et al. (2016) Wien Klin Wochenschr. 128:480.
  7. Niu, T. et al. (2016) J. Bone Miner. Res. 31:358.
  8. Scott, H.S. et al. (1993) Hum. Mol. Genet. 2:1471.

Alternate Names

alphaLIduronidase, IDA, IDUA

Entrez Gene IDs

3425 (Human); 15932 (Mouse); 360904 (Rat); 102116889 (Cynomolgus Monkey)

Gene Symbol

IDUA

UniProt

P35475.2

Additional alpha-L-Iduronidase/IDUA Products

Product Documents for Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF

For research use only

Customer Reviews for Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF and earn rewards!

Have you used Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human alpha-L-Iduronidase/IDUA His Protein, CF (11201-GH):

Materials
  • Assay Buffer: 50 mM NaOAc, 150 mM NaCl, 0.02% Brij-35 (w/v), pH 3.5
  • Development Buffer: 0.1 M Tris, pH 9.0
  • Recombinant Human IDUA (rhIDUA) (Catalog # 11201-GH)
  • Substrate: 4-methylumberlliferyl-alpha -L-Iduronide, 20 mM stock in DMSO
  • Black 96-well PlateFluorescent Plate Reader
  1. Dilute rhIDUA to 0.2 µg/mL in Assay Buffer. Minimize the number of dilution steps to obtain the best activity results.
  2. Dilute Substrate to 800 µM in Assay Buffer.
  3. Combine equal volumes of 0.2 µg/mL rhIDUA and 800 µM Substrate. Include a Substrate Blank by combining equal volumes of Assay Buffer and 800 µM Substrate.
  4. Incubate reactions and Substrate Blank at room temperature for 10 minutes.
  5. Dilute rhIDUA/substrate mixtures to 0.005 µg/mL of rhIDUA in Developing Buffer.
  6. Load 100 µL of the diluted rhIDUA/substrate mixtures into a plate.
  7. Read plate at excitation and emission wavelengths of 365 nm and 445 nm (top read), respectively, in endpoint mode.
  8. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Fluorescence* (RFU) x Conversion Factor** (pmol/RFU)
Incubation time (min) x amount of enzyme (µg)

    

*Adjusted for Substrate Blank
**Derived from calibration standard 4-methylumbelliferone
Per Well:
  • rhIDUA: 0.0005 µg
  • Substrate: 20 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes